The Advanced Therapeutics for Alzheimer’s Disease Review Board: A Multidisciplinary Model to Facilitate Safe Access to Lecenemab across the Sutter Health System

Armen Moughamian, Shawn Kile, Travis Urban, Chen Zhao, Michelle Manifield, Jean Minton · 2025

Read The Advanced Therapeutics for Alzheimer’s Disease Review Board: A Multidisciplinary Model to Facilitate Safe Access to Lecenemab across the Sutter Health System by Armen Moughamian, Shawn Kile, Travis Urban, Chen Zhao, Michelle Manifield, Jean Minton (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712105.txt.

Description

Armen Moughamian and co-authors described in 2025 how one large health system set up a review board to give Alzheimer's patients safe access to a new infusion drug. The drug can slow the disease but needs careful screening and monitoring, and brain specialists are in short supply.

Sutter Health serves over three million people in Northern California with only four dementia specialists. Its board mixes brain doctors, a scan specialist, a pharmacist, and a nurse guide, and meets weekly. Local neurologists send in cases and get advice, then prescribe near the patient's home. The board also rechecks patients over time for safety. The authors offer the model to widen fair access to such therapies.

Catalog record

CREATORArmen Moughamian, Shawn Kile, Travis Urban, Chen Zhao, Michelle Manifield, Jean Minton
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11712105

Browse the full library · About the Tower of Babel